🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Really interesting article as the #ACR20 is happening! Protective pre-existing antibodies for COVid-19! Dr. John Cush

Awesome poster- such a relevant clinical question - maybe we do not need to treat patients for hep B when they are hep B Ab+ when treated with IL6 and jaki abstract #0545 Dr. John Cush #ACr20 The Ohio State University Wexner Medical Center

Can we use urine testing ( and all the cells, proteins, complements, DNA, rna) to predict LN response? Plenary II Salem Almaani Brad H Rovin Dr. John Cush #ACR20 The Ohio State University Wexner Medical Center

Great thoughts-how do we define seronegative RA as well? more studies like this are needed for patient centered medicine! American College of Rheumatology Dr. John Cush The Ohio State University Wexner Medical Center #ACR20

Patient understanding is so important and the poor health outcomes physicians try to minimize- how do we do better? Numeracy is so important! Dr. John Cush #ACR20 Ellen Peters

If we are still not understanding the barriers behind recieving the flu vaccine in rheumatic patients- what is going to be different about a potential COVID-19 vaccine? So much more to learn! Abstract 1135 The Ohio State University Wexner Medical Center CreakyJoints.org Dr. John Cush #ACR20

Great poster-abstract 1260- chicken or egg- what comes first cognitive issues for patients with SLE then the Depression/anxiety or the opposite—-mental health is so important to address!! Dr. John Cush #ACR20

Great thoughts- goes to our lack of understanding that the right genetic host and the environmental stimulus and boom- autoimmune disease—- so much more to learn! Dr. John Cush #ACR20

So much more work to be done- the traditional tools for estimating CVD in rheumatic patients are likely not accurate especially patients with SLE- abstract 1286 Dr. John Cush #acr20

Please take the new telemedicine survey- how can we help our patients during these unique times! Dr. John Cush #ACR20

Important thoughts- how do we actually use the biologics in practice for the rare diseases that do not have many FDA approved options? Dr. John Cush #ACR20 abstract 1429

Awesome succinct guidelines!#acrbest #acr20 Dr. John Cush

Yau#y! Salem Almaani and go osu vasculitis team! The Ohio State University Wexner Medical Center Peter Mohler

Interesting Salem Almaani Lynn Fussner

Check out this weeks episode with my colleague alexa meara on why women suffer from autoimmune conditions more commonly then men. #womenshealthcare #midlifewomen

Considering the potential inequity #rheumatology and #arthritis patients may face in vaccine access, CRA SCR has released a position statement. This is an evolving field and with more data the statement will be updated. #lupus #canada CRA MakeRheum Spondylitis.org @SPONDYLITISCA

Thanks to all #lupus patients participating to the #VACOLUP study 🙏 Here is the 3rd weekly report about #SARSCoV2 #vaccines in #SLE: 339 participants. Adverse events reported in ~50% ➡️ Minor or moderate in ~80% with ~3% of medically-confirmed flare and no #Covid19 case.

Women in health care are at a breaking point — and they’re leaving 19thnews.org/2021/05/women-… via 19thnews. Really interesting read #WomenInSTEM

Ardem Patapoutian NIH NIH study sections truly are the great equalizer!